Ontruzant 150 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQR7U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,570
Award facts
- Contract value 100% obligated
- $22,569.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $22.6K delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ontruzant 150 mg vials, a biosimilar therapeutic agent. This firm fixed-price delivery order, which carries an ultimate completion date of December 10, 2025, is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal medical procurement requirements. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves military and veteran healthcare systems through its expansive portfolio of pharmaceutical products and medical supplies. The company's DLA contract vehicle supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This delivery order for Ontruzant represents a routine pharmaceutical supply transaction within AmerisourceBergen's ongoing role as a key provider of medical products across the federal government's military and defense healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DR26FQR7U?
SPE2DR26FQR7U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FQR7U worth?
The government has obligated $22,570 on SPE2DR26FQR7U.
Is contract SPE2DR26FQR7U an order under another contract?
Yes. SPE2DR26FQR7U is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQR7U competed?
The extent of competition for SPE2DR26FQR7U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award